Riskpilot← Back to searchSign inGet full accessSimonsson Science AB
ABActiveOrg 5567959050StockholmResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20091 employees
Revenue 2024
SEK 3K
-99% vs 2023
EBITDA margin
-15120.9%
+22% vs 2023
Equity ratio
95.0%
Financial strength
Net profit 2024
SEK 735K
+218% vs 2023
| Revenue | SEK 3K | -99% |
| EBITDA | SEK -445K | +22% |
| Net profit | SEK 735K | +218% |
| Total assets | SEK 8,8M | +6% |
| Equity | SEK 8,4M | +1% |
| Employees | 1 | — |
Legal name
Simonsson Science AB
Org number
5567959050
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
3 december 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet ska vara konsultation, utbildning och produktutveckling inom läkemedel, näring och hälsa samt närbesläktade områden. Handel med värdepapper samt idka därmed förenlig verksamhet.
Address
Stockholm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 528 | 203 | 394 | 225 | 3 |
| Staff expenses | — | — | −110 | −67 | −59 |
| EBITDA | 203 | −155 | −912 | −567 | −445 |
| Depreciation & amort. | −46 | −46 | −46 | −46 | −15 |
| EBIT | 157 | −201 | −958 | −613 | −459 |
| Net financials | 268 | 284 | 357 | 845 | 1 194 |
| Profit before tax | 426 | 83 | — | — | 735 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 426 | 83 | −601 | 231 | 735 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 349 | 9 147 | 8 305 | 8 345 | 8 830 |
| Equity | 9 164 | 9 067 | 8 277 | 8 313 | 8 391 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 185 | 79 | 29 | 32 | 439 |
| Total debt | 185 | 79 | 29 | 32 | 439 |
EBITDA margin
-15120.9%
This company
15.8%
Market median
-95802% vs market
20202024
Equity ratio
95.0%
This company
38.2%
Market median
+149% vs market
20202024
Return on equity
8.8%
This company
18.4%
Market median
-52% vs market
20202024
Net profit margin
25000.2%
This company
8.1%
Market median
+308544% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
KM Auditor Substitute | Auditor Substitute | 2022 – 2024 |
JK | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Simonsson Science AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Maria Francois | Auditor Substitute | 0 companies |
| Johanna Katarina Boive | Audit | 0 companies |
| Ulrika Sigrid Helena Simonsson | Board of Directors | 0 companies |
| Johan Georg Allan Simonsson | Deputy Board Member | 0 companies |